文献速递颈动脉与弓上血管

颈动脉支架取出的适应症与结局

Carotid Stent Explant Indications and Outcomes.
PubMed 文献 · Ann Vasc Surg · 2021-08-17

本研究回顾性分析2010-2020年单中心10例颈动脉支架取出病例,最常见的适应症为再狭窄(70.0%)和感染(30.0%),70.0%患者有症状。平均住院4.5天,30天死亡率、卒中及伤口感染均为0%。

要点

  • 再狭窄是颈动脉支架取出的最常见原因(70.0%),其中50.0%对血管成形术难治。
  • 感染占取出原因的30.0%,70.0%患者表现为症状。
  • 30天死亡率、卒中及术后伤口感染均为0%,提示手术可能安全。

核心结论

  • 本组颈动脉支架取出后30天死亡率、卒中和术后伤口感染均为0%,提示该手术可能安全实施。

研究设计与样本

  • 回顾性单中心病例系列,查询2010-2020年前瞻性维护的血管外科数据库及医院记录,共识别10例颈动脉支架取出患者。

主要发现

  • 7例(70.0%)因再狭窄取出支架,其中5例(50.0%)再狭窄对血管成形术难治。
  • 3例(30.0%)因感染取出支架,7例(70.0%)表现为症状。
  • 仅1例(12.5%)原颈动脉支架置入在本院完成,平均住院4.5天。
  • 1例出现声带麻痹但无需干预,无30天死亡、卒中或术后伤口感染(0%)。

临床怎么用

  • 对于颈动脉支架置入后出现难治性再狭窄或感染的患者,可考虑支架取出,但需认识证据来自小样本单中心回顾性研究。

局限性

  • 样本量小(仅10例),为单中心回顾性研究,结果需更大样本验证。
  • 仅1例(12.5%)原支架置入在本院完成,可能影响对整体人群的代表性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carotid artery stenting is an alternative to carotid endarterectomy, especially in patients deemed to have significant anatomic or medical risk for the latter. There is scant literature, however, on indications for and outcomes of carotid stent (CAS) explant. We sought to determine indications and outcomes of CAS explant at our institution. METHODS: We queried a prospectively maintained institutional vascular surgery database as well as hospital records to identify patients undergoing carotid stent explant from 2010-2020. Ten patients were identified. Their charts were reviewed to obtain demographic, comorbidity, procedural, and outcomes data. Data of particular interest were preoperative atherosclerotic factors, indications for CAS explant, carotid repair strategy, and 30-day post-procedural complications. Data were analyzed for ranges and means. RESULTS: Ten patients were identified. Comorbidity was common: all patients had at least 1 atherosclerotic risk factor, with hypertension and hypercholesterolemia being the most common. Seven (70.0%) patients had recurrent stenosis as the indication for explant. Seven (70.0%) presented symptomatically. Five (50.0%) cases of restenosis had been refractory to angioplasty. There were 3 (30.0%) instances of CAS explant due to infection. Only 1 (12.5%) index CAS was performed at our institution. There was a mean hospital length of stay of 4.5 days. One patient had vocal cord paralysis requiring no intervention. There was no (0%) 30-day mortality, stroke, or postoperative wound infections. CONCLUSIONS: Our series had 0% 30-day mortality, stroke, and postoperative wound infection suggesting that CAS explant may be performed safely. Our series is small but represents the largest single institution series to date. This procedure may become increasingly common in the coming years with the more frequent use of CAS; additional data is needed to rigorously understand outcomes.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Small C, Thompson T, Scali S, et al. Carotid Stent Explant Indications and Outcomes. Ann Vasc Surg. 2021. PMID: 34411671. doi:10.1016/j.avsg.2021.05.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。